Cited by 190Virus-based gene therapy researchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver

Open access

Nakai, Hiroyuki, Wu, Xiaolin, Fuess, Sally, Storm, Theresa A., Munroe, David, Montini, Eugenio, Burgess, Shawn M., Grompe, Markus, Kay, Mark A.·2005·Journal of Virology

DOI 10.1128/jvi.79.6.3606-3614.2005PMC PMC1075691

Open this paper in CoChat — free account

Abstract

Recombinant adeno-associated virus (rAAV) vector holds promise for gene therapy. Despite a low frequency of chromosomal integration of vector genomes, recent studies have raised concerns about the risk of rAAV integration because integration occurs preferentially in genes and accompanies chromosomal deletions, which may lead to loss-of-function insertional mutagenesis. Here, by analyzing 347 rAAV integrations in mice, we elucidate novel features of rAAV integration: the presence of hot spots for integration and a strong preference for integrating near gene regulatory sequences. The most prominent hot spot was a harmless chromosomal niche in the rRNA gene repeats, whereas nearly half of the integrations landed near transcription start sites or CpG islands, suggesting the possibility of activating flanking cellular disease genes by vector integration, similar to retroviral gain-of-function insertional mutagenesis. Possible cancer-related genes were hit by rAAV integration at a frequency of 3.5%. In addition, the information about chromosomal changes at 218 integration sites and 602 breakpoints of vector genomes have provided a clue to how vector terminal repeats and host chromosomal DNA are joined in the integration process. Thus, the present study provides new insights into the risk of rAAV-mediated insertional mutagenesis and the mechanisms of rAAV integration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/jvi.79.6.3606-3614.2005

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Mobile DNA II
(2007) · Wiley eBooks · doi:10.1128/9781555817954 · Cited by 1,311
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Self-citation
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B. E., Chew, A. K., Tai, S. J., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,019
Self-citation
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R. P., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 546

Show all 33 references

Research works printed but not linked: 1

10.1007/BF00352115 · DOI

Sorted by citations

Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
State-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 699
Self-citation
AAV vector integration sites in mouse hepatocellular carcinoma
Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662
[19] Gene Expression Omnibus: Microarray Data Storage, Submission, Retrieval, and Analysis
Barrett, T., & Edgar, R. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)11019-8 · Cited by 511
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells
Nguyen, G. N., Everett, J. K., Kafle, S., Roche, A. M., Raymond, H. E., Leiby, J. S., Wood, C. M., Assenmacher, C., Merricks, E. P., Long, C. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0741-7 · Cited by 438
Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors
Baum, C., Kustikova, O. S., Modlich, U., Li, Z., & Fehse, B. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.253 · Cited by 369
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
Nathwani, A. C., Rosales, C., McIntosh, J., Rastegarlari, G., Nathwani, D., Raj, D., Nawathe, S., Waddington, S. N., Bronson, R., Jackson, S., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.274 · Cited by 345
Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle
Penaud‐Budloo, M., Guiner, C. L., Nowrouzi, A., Toromanoff, A., Chérel, Y., Chenuaud, P., Schmidt, M., Kalle, C. V., Rolling, F., Moullier, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00649-08 · Cited by 322
High-Resolution Genome-Wide Mapping of Transposon Integration in Mammals
Yant, S. R., Wu, X., Huang, Y., Garrison, B. S., Burgess, S. M., & Kay, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2085-2094.2005 · Cited by 322
Self-citation
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Niemeyer, G. P., Herzog, R. W., Mount, J., Arruda, V. R., Tillson, D. M., Hathcock, J., van Ginkel, F. W., High, K. A., & Lothrop, C. D. (2009) · Blood · doi:10.1182/blood-2008-10-181479 · Cited by 276
Assessing the potential for AAV vector genotoxicity in a murine model
Li, H., Malani, N., Hamilton, S. R., Schlachterman, A., Bussadori, G., Edmonson, S. A., Shah, R., Arruda, V. R., Mingozzi, F., Wright, J. F., et al. (2010) · Blood · doi:10.1182/blood-2010-08-302729 · Cited by 244
Characterization of Genome Integrity for Oversized Recombinant AAV Vector
Dong, B., Nakai, H., & Xiao, W. (2010) · Molecular Therapy · doi:10.1038/mt.2009.258 · Cited by 230
Self-citation
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 229
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
Sabatino, D. E., Bushman, F. D., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R. E., Eggan, K. C., Gao, G., Gil-Fariña, I., Kay, M. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.004 · Cited by 222
Self-citation
A Transposon and Transposase System for Human Application
Hackett, P. B., Largaespada, D. A., & Cooper, L. J. N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.2 · Cited by 209
Adeno-associated virus vector integration.
Deyle, D. R., & Russell, D. W. (2009) · PubMed · Cited by 206
Selection of Target Sites for Mobile DNA Integration in the Human Genome
Berry, C., Hannenhalli, S., Leipzig, J., & Bushman, F. (2006) · PLoS Comput. Biol. · doi:10.1371/journal.pcbi.0020157 · Cited by 210
Viral vectors for therapy of neurologic diseases
Choudhury, S. R., Hudry, E., Maguire, C. A., Sena-Esteves, M., Breakefield, X. O., & Grandi, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.013 · Cited by 190
Recombinant AAV Integration Is Not Associated with Hepatic Genotoxicity in Nonhuman Primates and Patients
Gil-Farina, I., Fronza, R., Kaeppel, C., Lopez-Franco, E., Ferreira, V., D'Avola, D., Benito, A., Prieto, J., Petry, H., Gonzalez-Aseguinolaza, G., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.52 · Cited by 179
Adeno-Associated Virus Integration: Virus versus Vector
Smith, R. H. (2008) · Gene Therapy · doi:10.1038/gt.2008.55 · Cited by 178
Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells
Miller, D. G., Trobridge, G. D., Petek, L. M., Jacobs, M. A., Kaul, R., & Russell, D. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11434-11442.2005 · Cited by 175
Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene Transfer
Kwon, I., & Schaffer, D. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9431-0 · Cited by 170
Treatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155
Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡
Paulk, N. K., Wursthorn, K., Wang, Z., Finegold, M. J., Kay, M. A., & Grompe, M. (2010) · Hepatology · doi:10.1002/hep.23481 · Cited by 135
Self-citation
AAV-Mediated Liver-Directed Gene Therapy
Sands, M. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_6 · Cited by 141
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
Ferrari, S., Jacob, A., Cesana, D., Laugel, M., Beretta, S., Varesi, A., Unali, G., Conti, A., Canarutto, D., Albano, L., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.09.001 · Cited by 133
Self-citation
Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
Guan, S., Munder, A., Hedtfeld, S., Braubach, P., Glage, S., Zhang, L., Lienenklaus, S., Schultze, A., Hasenpusch, G., Garrels, W., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0358-x · Cited by 130
Adeno-associated virus in the liver: natural history and consequences in tumour development
Bella, T. L., Imbeaud, S., Péneau, C., Mami, I., Datta, S., Bayard, Q., Caruso, S., Hirsch, T. Z., Caldéraro, J., Morcrette, G., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318281 · Cited by 130
Precise hit: adeno-associated virus in gene targeting
Vasileva, A., & Jessberger, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1266 · Cited by 135
AAV integration in human hepatocytes
Dalwadi, D. A., Calabria, A., Tiyaboonchai, A., Posey, J., Naugler, W. E., Montini, E., & Grompe, M. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.08.031 · Cited by 130
Self-citation
Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications
Gaj, T., Epstein, B. E., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.151 · Cited by 124
Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype
Grimm, D., Pandey, K., Nakai, H., Storm, T. A., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.1.426-439.2006 · Cited by 118
Self-citation
Measles and rubella elimination in the WHO Region for Europe: progress and challenges
O’Connor, P. M., Jankovic, D., Muscat, M., Mamou, M. C. B., Reef, S. E., Papania, M. J., Singh, S., Kaloumenos, T., Butler, R., & Datta, S. S. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.003 · Cited by 123
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dalwadi, D. A., Torrens, L., Abril‐Fornaguera, J., Pinyol, R., Willoughby, C. E., Posey, J., Llovet, J. M., Lanciault, C., Russell, D. W., Grompe, M., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.018 · Cited by 106
Self-citation
miRNA cassettes in viral vectors: Problems and solutions
Liu, Y. P., & Berkhout, B. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.014 · Cited by 101
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction
Wang, J., Xie, J., Lu, H., Chen, L., Hauck, B., Samulski, R. J., & Xiao, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702778104 · Cited by 103
In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors
Richter, M., Saydaminova, K., Yumul, R., Krishnan, R., Liu, J., Nagy, E.-E., Singh, M., Izsvák, Z., Cattaneo, R., Uckert, W., et al. (2016) · Blood · doi:10.1182/blood-2016-04-711580 · Cited by 99
Patterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity
Rosas, L. E., Grieves, J. L., Zaraspe, K., Perle, K. M. D. L., Fu, H., & McCarty, D. M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.197 · Cited by 99
Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease
Stephen, S. L., Freestone, K., Dunn, S., Twigg, M. W., Homer‐Vanniasinkam, S., Walker, J. H., Wheatcroft, S. B., & Ponnambalam, S. (2010) · International Journal of Hypertension · doi:10.4061/2010/646929 · Cited by 97
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera ® )
Salmon, F., Grosios, K., & Petry, H. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.852065 · Cited by 96
Chromosomal Integration of Adenoviral Vector DNA In Vivo
Stephen, S. L., Montini, E., Sivanandam, V. G., Al-Dhalimy, M., Kestler, H. A., Finegold, M. J., Grompe, M., & Kochanek, S. (2010) · Journal of Virology · doi:10.1128/jvi.00751-10 · Cited by 91
Self-citation
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0052-2014 · Cited by 93
Molecular Analysis of Chromosomal Rearrangements in Mammalian Cells After ø C31-Mediated Integration
Ehrhardt, A., Engler, J. A., Xu, H., Cherry, A. M., & Kay, M. A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1077 · Cited by 86
Self-citation
Gene therapy for haemophilia: a long and winding road
High, K. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04369.x · Cited by 84
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 83
Transfection of cells using flow-through electroporation based on constant voltage
Geng, T., Zhan, Y., Wang, J., & Lu, C. (2011) · Nature Protocols · doi:10.1038/nprot.2011.360 · Cited by 80
Gene therapy for liver diseases — progress and challenges
Zabaleta, N., Unzu, C., Weber, N. D., & González‐Aseguinolaza, G. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00729-0 · Cited by 78
miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repression
Valdmanis, P. N., Kim, H. K., Chu, K. C., Zhang, F., Xu, J., Munding, E. M., Shen, J. Y., & Kay, M. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07786-7 · Cited by 74
Self-citation
Adeno-associated Vector Toxicity—To Be or Not to Be?
Büning, H., & Schmidt, M. (2015) · Molecular Therapy · doi:10.1038/mt.2015.182 · Cited by 71
Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine
McIntosh, J. H., Cochrane, M., Cobbold, S., Waldmann, H., Nathwani, S. A., Davidoff, A. M., & Nathwani, A. C. (2012) · Gene Therapy · doi:10.1038/gt.2011.64 · Cited by 70
The Role of DNA-PKcs and Artemis in Opening Viral DNA Hairpin Termini in Various Tissues in Mice
Inagaki, K., Ma, C., Storm, T. A., Kay, M. A., & Nakai, H. (2007) · Journal of Virology · doi:10.1128/jvi.01225-07 · Cited by 70
Self-citation
The Threefold Protrusions of Adeno-Associated Virus Type 8 Are Involved in Cell Surface Targeting as Well as Postattachment Processing
Raupp, C., Naumer, M., Müller, O. J., Gurda, B. L., Agbandje‐McKenna, M., & Kleinschmidt, J. A. (2012) · Journal of Virology · doi:10.1128/jvi.00209-12 · Cited by 64
Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1
Kuck, D., Lau, T., Leuchs, B., Kern, A., Müller, M., Gissmann, L., & Kleinschmidt, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2621-2630.2006 · Cited by 66
Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy
Hackett, C. S., Geurts, A. M., & Hackett, P. B. (2007) · Genome biology · doi:10.1186/gb-2007-8-s1-s12 · Cited by 63
Homologous recombination is required for AAV-mediated gene targeting
Vasileva, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl455 · Cited by 62
Designing Heart Performance by Gene Transfer
Davis, J., Westfall, M. V., Townsend, D., Blankinship, M. J., Herron, T. J., Guerrero‐Serna, G., Wang, W., Devaney, E. J., & Metzger, J. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00039.2007 · Cited by 60
Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors
Ohbayashi, F., Balamotis, M. A., Kishimoto, A., Aizawa, E., Diaz, A., Hasty, P., Graham, F. L., Caskey, C. T., & Mitani, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506598102 · Cited by 61
DNA ligase III and DNA ligase IV carry out genetically distinct forms of end joining in human somatic cells
Oh, S., Harvey, A., Zimbric, J., Wang, Y., Nguyen, T., Jackson, P. J., & Hendrickson, E. A. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.04.015 · Cited by 58
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 63
ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · BMC Genomics · doi:10.1186/s12864-020-6655-4 · Cited by 60
Frequency and Spectrum of Genomic Integration of Recombinant Adeno-Associated Virus Serotype 8 Vector in Neonatal Mouse Liver
Inagaki, K., Piao, C., Kotchey, N. M., Wu, X., & Nakai, H. (2008) · Journal of Virology · doi:10.1128/jvi.01001-08 · Cited by 58
Self-citation
DNA Palindromes with a Modest Arm Length of ≳20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice
Inagaki, K., Lewis, S. M., Wu, X., Ma, C., Munroe, D. J., Fuess, S., Storm, T. A., Kay, M. A., & Nakai, H. (2007) · Journal of Virology · doi:10.1128/jvi.00963-07 · Cited by 54
Self-citation
Frequent Endonuclease Cleavage at Off-target Locations In Vivo
Petek, L. M., Russell, D. W., & Miller, D. G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.35 · Cited by 54
AAV Vectors, Insertional Mutagenesis, and Cancer
Russell, D. W. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300299 · Cited by 54
The Mechanism of Gene Targeting in Human Somatic Cells
Kan, Y., Ruis, B. L., Lin, S. G., & Hendrickson, E. A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004251 · Cited by 50
Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno‐associated virus/piggyBac transposase gene delivery system
Cunningham, S. C., Siew, S., Hallwirth, C. V., Bolitho, C., Sasaki, N., Garg, G., Michael, I. P., Hetherington, N. A., Carpenter, K. H., de Alencastro, G., et al. (2015) · Hepatology · doi:10.1002/hep.27842 · Cited by 48
Gene Therapy Progress and Prospects – Vectorology: design and production of expression cassettes in AAV vectors
Bec, C. L., & Douar, A. M. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302724 · Cited by 49
AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence
Wang, Z., Lisowski, L., Finegold, M. J., Nakai, H., Kay, M. A., & Grompe, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.157 · Cited by 44
Self-citation
Deciphering conundrums of adeno-associated virus liver-directed gene therapy: focus on hemophilia
Pierce, G. F., Fong, S., Long, B. R., & Kaczmarek, R. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.12.005 · Cited by 47
AAV vectors and tumorigenicity
Kay, M. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1111 · Cited by 43
Self-citation
Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools
Coates, C. J., Kaminski, J., Summers, J. B., Segal, D. J., Miller, A. D., & Kolb, A. F. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.06.009 · Cited by 43
Barriers for retinal gene therapy: separating fact from fiction.
Kumar-Singh, R. (2008) · Vision Research · doi:10.1016/j.visres.2008.05.005 · Cited by 43
Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic Integration
Zhang, W., Mück-Häusl, M., Wang, J., Sun, C., Gebbing, M., Miskey, C., Ivics, Z., Izsvák, Z., & Ehrhardt, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075344 · Cited by 42
Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies
Li, C., Psatha, N., Wang, H., Singh, M., Samal, H. B., Zhang, W., Ehrhardt, A., Izsvák, Z., Papayannopoulou, T., & Lieber, A. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.02.004 · Cited by 42
Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease
Brommel, C. M., Cooney, A. L., & Sinn, P. L. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.138 · Cited by 43
Fah Knockout Animals as Models for Therapeutic Liver Repopulation
Grompe, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_20 · Cited by 42
Self-citation
Emerging Strategies for the Treatment of Hereditary Metabolic Storage Disorders
Brady, R. O. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.237 · Cited by 40
Long-Term Sex-Biased Correction of Circulating Propionic Acidemia Disease Markers by Adeno-Associated Virus Vectors
Guenzel, A. J., Collard, R., Kraus, J. P., Matern, D., & Barry, M. A. (2015) · Human Gene Therapy · doi:10.1089/hum.2014.126 · Cited by 40
Fate of Recombinant Adeno-Associated Viral Vector Genomes During DNA Double-Strand Break-Induced Gene Targeting in Human Cells
Gellhaus, K., Cornu, T. I., Heilbronn, R., & Cathomen, T. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.167 · Cited by 40
Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment
Wong, G. K. Y., & Chiu, A. T. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.07.005 · Cited by 37
RNA interference–induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice
Valdmanis, P. N., Gu, S., Chu, K. C., Jin, L., Zhang, F., Munding, E. M., Zhang, Y., Huang, Y., Kutay, H., Ghoshal, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4079 · Cited by 38
Self-citation
Ribosomal DNA Integrating rAAV-rDNA Vectors Allow for Stable Transgene Expression
Lisowski, L., Lau, A., Wang, Z., Zhang, Y., Zhang, F., Grompe, M., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.164 · Cited by 35
Self-citation
rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault
Valdmanis, P. N., Lisowski, L., & Kay, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.220 · Cited by 38
Self-citation
Hybrid Adeno-Associated Viral Vectors Utilizing Transposase-Mediated Somatic Integration for Stable Transgene Expression in Human Cells
Zhang, W., Solanki, M., Müther, N., Ebel, M., Wang, J., Sun, C., Izsvák, Z., & Ehrhardt, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076771 · Cited by 35
Preferential Targeting of Disseminated Liver Tumors Using a Recombinant Adeno-Associated Viral Vector
Peruta, M. D., Badar, A., Rosales, C., Chokshi, S., Kia, A., Nathwani, D., Galante, E., Yan, R., Årstad, E., Davidoff, A. M., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2014.052 · Cited by 35
AAV-Mediated Gene Targeting Is Significantly Enhanced by Transient Inhibition of Nonhomologous End Joining or the Proteasome In Vivo
Paulk, N. K., Loza, L. I. M., Finegold, M. J., & Grompe, M. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.038 · Cited by 35
Self-citation
Stable Integration of Recombinant Adeno-Associated Virus Vector Genomes After Transduction of Murine Hematopoietic Stem Cells
Han, Z., Li, Z., Maina, N., Hu, Z., Li, X., Chouthai, N. S., Bischof, D., Weigel-Kelley, K. A., Slayton, W. B., Yöder, M. C., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.161 · Cited by 35
Prevalent and Disseminated Recombinant and Wild-Type Adeno-Associated Virus Integration in Macaques and Humans
Martins, K. M., Breton, C. A., Zheng, Q., Zhang, Z., Latshaw, C., Greig, J. A., & Wilson, J. M. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.134 · Cited by 37
Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice
Anguela, X. M., Tafuro, S., Roca, C., Callejas, D., Agudo, J., Obach, M., Ribera, A., Ruzo, A., Mann, C. J., Casellas, A., et al. (2012) · Diabetes · doi:10.2337/db11-1776 · Cited by 32
Recombinant adeno-associated Virus: Clinical Application and Development As a gene-therapy Vector
Xiao, P.-J., Lentz, T. B., & Samulski, R. J. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.63 · Cited by 31
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
Truong, A., Wong, T. Y., & Khachigian, L. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0709-z · Cited by 27
Advances in understanding disease mechanisms and potential treatments for Crigler–Najjar syndrome
Bortolussi, G., & Muro, A. F. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1495558 · Cited by 27
Gene therapy for lysosomal storage disorders
Gritti, A. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.582036 · Cited by 30
Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing
Kaulich, M., & Dowdy, S. F. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0545 · Cited by 25
Intégration des vecteurs AAV et mutagenèse insertionnelle
Rossi, A., & Salvetti, A. (2016) · médecine/sciences · doi:10.1051/medsci/20163202010 · Cited by 29
Development and Validation of Novel AAV2 Random Libraries Displaying Peptides of Diverse Lengths and at Diverse Capsid Positions
Naumer, M., Ying, Y., Michelfelder, S., Reuter, A., Trepel, M., Müller, O. J., & Kleinschmidt, J. A. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.139 · Cited by 24
Gene Therapy for Coagulation Disorders
Swystun, L. L., & Lillicrap, D. (2016) · Circulation Research · doi:10.1161/circresaha.115.307015 · Cited by 24
Early Interaction of Adeno-Associated Virus Serotype 8 Vector with the Host Immune System Following Intramuscular Delivery Results in Weak but Detectable Lymphocyte and Dendritic Cell Transduction
Gernoux, G., Guilbaud, M., Dubreil, L., Larcher, T., Babarit, C., Ledevin, M., Jaulin, N., Planel, P., Moullier, P., & Adjali, O. (2014) · Human Gene Therapy · doi:10.1089/hum.2014.070 · Cited by 22
Exploiting Natural Diversity of AAV for the Design of Vectors with Novel Properties
Gao, G., Li, Z., & Danos, O. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_4 · Cited by 24
Perinatal systemic gene delivery using adeno-associated viral vectors
Karda, R., Buckley, S. M. K., Mattar, C. N. Z., Ng, J., Massaro, G., Hughes, M. P., Kurian, M. A., Baruteau, J., Gissen, P., Chan, J. K. Y., et al. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00089 · Cited by 22

Authors: Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A.
Affiliations: Stanford Medicine (US)
National Institutes of Health (US)
Oregon Health & Science University (US)
Corresponding author: Nakai, Hiroyuki
ORCID: Nakai, Hiroyuki
Wu, Xiaolin
Storm, Theresa A.
Montini, Eugenio
Burgess, Shawn M.
Grompe, Markus
Kay, Mark A.
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 2005-03-15
Volume: 79
Issue: 6
Pages: 3606-3614
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.79.6.3606-3614.2005
PMC: PMC1075691
OpenAlex: W2151713466
Cited by: 190
References: 33
Citations by year: 2026: 4 · 2025: 2 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 1 · 2020: 11 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 10 · 2015: 13 · 2014: 8 · 2013: 6 · 2012: 13
FWCI: 10.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
PubMed Central (publishedVersion)
Funders: U.S. Department of Health and Human Services
National Institutes of Health (n01co12400-79-0-22, N01-CO-12400)
National Heart, Lung, and Blood Institute (HL66948, U01HL066948)
National Cancer Institute (N01CO12400, N01-CO-012400)
National Institute of Diabetes and Digestive and Kidney Diseases (DK18252, DK068636, R21DK068636)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords: adeno-associated virus, insertional mutagenesis, liver, CpG islands, transcription start sites, cancer genes, chromosomal breakpoints, terminal repeats, gene therapy safety, mice
MeSH terms: Dependovirus, Animals, Genetic Vectors, Oncogenes, Regulatory Sequences, Nucleic Acid, Genetic Therapy, Mutagenesis, Insertional, Virus Integration, CpG Islands, Genes, rRNA, Hepatocytes, Transcription Initiation Site, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks